After washing the wells, bound biotin-labeled NRG1 WT was determined by using streptavidin HRP conjugate

After washing the wells, bound biotin-labeled NRG1 WT was determined by using streptavidin HRP conjugate. and Erk1/2 activation in MCF-7 and T47D human breast cancer cells. This suggests that direct MDR-1339 integrin binding to NRG1 is critical for NRG1/ErbB signaling. Notably, stimulation of cells with WT NRG1 induced co-precipitation of ErbB3 with 64 and with v3 to a much lower extent. This suggests that WT NRG1 induces integrin-NRG1-ErbB3 ternary complex formation. In contrast, the 3KE mutant was much less effective in inducing ternary complex formation Rabbit polyclonal to APBA1 than WT NRG1, suggesting that this process depends on the ability of NRG1 to bind to integrins. These results suggest that direct NRG1-integrin interaction mediates integrin-ErbB cross-talk and that MDR-1339 64 plays a major role in NRG-ErbB signaling in these cancer cells. Keywords:Growth Factors, Integrin, Mutant, Receptor-tyrosine Kinase, Signal Transduction, Site-directed Mutagenesis, ErbB, Neuregulin == Introduction == The neuregulins (NRGs)2are a family of four structurally related proteins that are part of the EGF family of proteins (NRG14) (14). Transmembrane NRGs typically function as precursor molecules that are cleaved by metalloproteases. This results in the release of the extracellular domain that may subsequently bind to nearby receptors (autocrine/paracrine action). NRGs contain an epidermal growth factor (EGF)-like motif that binds and activates receptor-tyrosine kinases in the EGF receptor (ErbBs) family. Neuregulin-1 (NRG1) binds to ErbB3 and ErbB4. NRG1 has 11 isoforms (5). MDR-1339 NRG1 plays essential roles in the nervous system, heart, and breast. NRG1 signaling is involved in the development and functions of several other organ systems and human diseases, including schizophrenia (6), coronary heart diseases (7), and cancer (8). Targeted deletion of ErbB2, ErbB3, ErbB4, or NRG1 in mice leads to developmental abnormalities that are severe in the nervous system and lethal in the cardiovascular system (911). In cancer the interaction between ErbB receptors and ligands such as NRGs plays an important role in tumor growth. The EGF-like motif of NRGs is essential and sufficient for receptor binding and activation as well as promoting tumorigenesis (12). The presence of the autocrine loop is one of the causes that induces aberrant ErbB receptor activation and has been correlated with cancer development and progression. Disrupting this autocrine loop may provide an important therapeutic measure to control cancer cell growth (13). Integrins have been shown to cross-talk with receptor-tyrosine kinase in growth factor signaling (14). Integrins are a family of cell adhesion receptors that recognize extracellular matrix ligands and cell surface ligands (15). Integrins are transmembrane heterodimers, and at least 18 and 8 subunits are known (16). Integrins are involved in signal transduction upon ligand binding, and their functions are in turn regulated by signals from within the cell (15). It has been reported that there is a positive correlation between v3 integrin levels and overexpression of NRG associated with melanoma tumor progression and metastasis (1719). It has been proposed that NRG1 may play a key role in the regulation of v3 integrin expression and in its signaling functions (20). Integrin 64 is a receptor for the laminin family of extracellular matrix proteins, and its expression is associated with poor patient prognosis and reduced survival in a variety of human cancers (21). The 4 integrin subunit was originally identified as a tumor-related antigen expressed in metastatic cancer (22). In contrast with its function in regulating stable adhesion through the formation of hemidesmosomes in normal epithelial cells, 64 promotes motility and invasion in carcinoma cells (23). Moreover, suppression of 64 expression by siRNA diminishes invasive potential (24). Cross-talk between growth factor receptors and integrins plays a role in growth factor signaling. In current.